Rockwell Medical, Inc. (RMTI) Financials
RMTI Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 52.6 million | 31.1 million |
2023-06-30 | 38.0 million | 28.5 million |
2023-03-31 | 40.5 million | 27.9 million |
2022-12-31 | 46.6 million | 32.5 million |
RMTI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -3.8 million | 212000 |
2023-06-30 | -1.8 million | 309000 |
2023-03-31 | -4.0 million | 193000 |
2022-12-31 | -678000 | 220000 |
RMTI Net Income
No data available :(
RMTI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 11.7 million | - | 5.4 million |
2023-06-30 | 9.0 million | 4.7 million | 5.9 million |
2023-03-31 | 16.8 million | 6.1 million | 6.2 million |
2022-12-31 | 21.5 million | - | 6.7 million |
RMTI Shares Outstanding
RMTI Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 16000 | 494000 | 2.9 million | 556000 |
2023-06-30 | 80000 | 167000 | 3.3 million | 530000 |
2023-03-31 | 145000 | 278000 | 3.3 million | 498000 |
2022-12-31 | 84000 | 156000 | 3.8 million | 352000 |
RMTI Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 23.8 million | 21.6 million |
2023-06-30 | 18.1 million | 17.0 million |
2023-03-31 | 19.7 million | 17.1 million |
2022-12-31 | 19.3 million | 17.0 million |
RMTI
Price: $1.46
52 week price:
Earnings Per Share: -0.37 USD
P/E Ratio: -1.36
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 309500
Ebitda: -4.9 millionMarket Capitalization: 47.4 million